2024

• Nindra, U., Shivasabesan, G., Mellor, R., Chua, W., Ng, W., Karikios, D., Richards, B., Liu, J. (2024). Evaluating Systemic Burnout in Medical Oncology Through a National Oncology Mentorship Program. JCO Oncology Practice, 20(4), 549-557. [More Information]
• Padhi, S., Shrestha, P., Alamgeer, M., Stevanovic, A., Karikios, D., Rajamani, A., Subramaniam, A. (2024). Oncology and intensive care doctors' perception of intensive care admission of cancer patients: A cross-sectional national survey. Australian Critical Care, 37(4), 520-529. [More Information]
• Goldsbury, D., Haywood, P., Pearce, A., Karikios, D., Canfell, K., Steinberg, J., Weber, M. (2024). Out-of-pocket health care expenses for people with and without cancer, New South Wales, 2020: a cross-sectional study. Medical Journal of Australia. [More Information]

2023

• Chatterton, S., Xi, S., Jia, J., Krause, M., Long, G., Atkinson, V., Menzies, A., Fernando, S., Boyle, T., Kwok, S., Duggins, A., Karikios, D., Parratt, J. (2023). Case series: Immune checkpoint inhibitor-induced transverse myelitis. Frontiers in Neurology, 14. [More Information]
• McLoone, J., Chan, R., Varlow, M., Whittaker, K., Lindsay, D., Thamm, C., Leigh, L., Muir, L., Mackay, G., Karikios, D., Goldsbury, D., et al (2023). Challenges and solutions to cancer-related financial toxicity according to Australian health professionals: qualitative results from a national survey. Supportive Care in Cancer, 31(7). [More Information]
• Ngo, P., Karikios, D., Goldsbury, D., Wade, S., Lwin, Z., Hughes, B., Fong, K., Canfell, K., Weber, M. (2023). Development and Validation of txSim: A Model of Advanced Lung Cancer Treatment in Australia. PharmacoEconomics, 41(11), 1525-1537. [More Information]
• Cressman, S., Weber, M., Ngo, P., Wade, S., Behar-Harpaz, S., Caruana, M., Tremblay, A., Manser, R., Stone, E., Atkar-Khattra, S., Karikios, D., Canfell, K., et al (2023). Economic impact of using risk models for eligibility selection to the International lung screening Trial. Lung Cancer, 176, 38-45. [More Information]
• Jenei, K., Raymakers, A., Bayle, A., Berger-Thürmel, K., Cherla, A., Honda, K., Jackson, C., Karikios, D., Trapani, D., Berry, S., et al (2023). Health technology assessment for cancer medicines across the G7 countries and Oceania: an international, cross-sectional study. The Lancet Oncology, 24(6), 624-635. [More Information]
• Pal, A., Smith, B., Allan, C., Karikios, D., Boyle, F. (2023). Improving Access to Cancer Clinical Trials for Patients from Culturally and Linguistically Diverse Backgrounds in Australia: A Survey of Clinical and Research Professionals. JCO Oncology Practice, 19(11), 1039-1047. [More Information]
• Gordon, L., Nabukalu, D., Chan, R., Goldsbury, D., Hobbs, K., Hunt, L., Karikios, D., Mackay, G., Muir, L., Leigh, L., et al (2023). Opinions and strategies of Australian health professionals on tackling cancer-related financial toxicity: A nationwide survey. Asia-Pacific Journal of Clinical Oncology, 19(1), 126-135. [More Information]
• Kumari, S., Karikios, D., Yeghiaian-Alvandi, R., Flynn, P., Morgan, L., Kay, L., Ding, P. (2023). Treatment patterns and long-term survival outcomes for patients with stage III non-small cell lung cancer: A retrospective study. Asia-Pacific Journal of Clinical Oncology. [More Information]

2022

• Lim, J., Murphy, A., Wong, S., Nagrial, A., Karikios, D., Daneshvar, D., McCloy, R., Steinmann, A., O'Toole, S., Chin, V. (2022). Activin-A, Growth Differentiation Factor-11 and Transforming Growth Factor-β as predictive biomarkers for platinum chemotherapy in advanced non-small cell lung cancer. Cancer Treatment and Research Communications, 32. [More Information]
• Ngo, P., Cressman, S., Behar-Harpaz, S., Karikios, D., Canfell, K., Weber, M. (2022). Applying utility values in cost-effectiveness analyses of lung cancer screening: A review of methods. Lung Cancer, 166, 122-131. [More Information]
• Pokorny, A., Moynihan, R., Fox, P., Karikios, D., Bero, L., Mintzes, B. (2022). Australian Cancer Physicians and the Pharmaceutical Industry: A Survey of Attitudes and Interactions. JCO Oncology Practice, 18(7), E1154-E1163. [More Information]
• Agarwal, A., Karikios, D., Stockler, M., Morton, R. (2022). Discussion of costs and financial burden in clinical practice: A survey of medical oncologists in Australia. PloS One, 17(10 October). [More Information]
• Yu, X., Yap, M., Cheng, E., Ngo, P., Vaneckova, P., Karikios, D., Canfell, K., Weber, M. (2022). Evaluating Prognostic Factors for Sex Differences in Lung Cancer Survival: Findings From a Large Australian Cohort. Journal of Thoracic Oncology, 17(5), 688-699. [More Information]
• Ngo, P., Wade, S., Vaneckova, P., Behar-Harpaz, S., Caruana, M., Cressman, S., Tammemagi, M., Karikios, D., Canfell, K., Weber, M. (2022). Health utilities for participants in a population-based sample who meet eligibility criteria for lung cancer screening. Lung Cancer, 169, 47-54. [More Information]
• Ngo, P., Goldsbury, D., Karikios, D., Yap, S., Yap, M., Egger, S., O'Connell, D., Ball, D., Fong, K., Pavlakis, N., Rankin, N., Canfell, K., Weber, M., et al (2022). Lung cancer treatment patterns and factors relating to systemic therapy use in Australia. Asia-Pacific Journal of Clinical Oncology, 18(5), e235-e246. [More Information]

2021

• Hasmat, S., Howle, J., Karikios, D., Carlino, M., Veness, M. (2021). Immunotherapy in advanced Merkel cell carcinoma: Sydney west cancer network experience. Journal of Medical Imaging and Radiation Oncology, 65(6), 760-767. [More Information]
• Chazan, G., Franchini, F., Alexander, M., Banerjee, S., Mileshkin, L., Blinman, P., Zielinski, R., Karikios, D., Pavlakis, N., Peters, S., et al (2021). Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians. ESMO Open, 6(5), 100224. [More Information]
• Kanjanapan, Y., Blinman, P., Underhill, C., Karikios, D., Segelov, E., Yip, D. (2021). Medical Oncology Group of Australia position statement: COVID-19 vaccination in patients with solid tumours. Internal Medicine Journal, 51(6), 955-959. [More Information]
• Agarwal, A., Livingstone (nee Ratcliffe), A., Karikios, D., Stockler, M., Beale, P., Morton, R. (2021). Physician-patient communication of costs and financial burden of cancer and its treatment: a systematic review of clinical guidelines. BMC Cancer, 21(1), 1036. [More Information]
• Pal, A., Stapleton, S., Yap, C., Lai-Kwon, J., Daly, R., Magkos, D., Baikady, B., Minchom, A., Banerji, U., De Bono, J., Karikios, D., Boyle, F., et al (2021). Study protocol for a randomised controlled trial of enhanced informed consent compared to standard informed consent to improve patient understanding of early phase oncology clinical trials (CONSENT). BMJ Open, 11(9), e049217. [More Information]

2020

• Segelov, E., Underhill, C., Prenen, H., Karapetis, C., Jackson, C., Nott, L., Clay, T., Pavlakis, N., Sabesan, S., Heywood, E., Karikios, D., et al (2020). Practical considerations for treating patients with cancer in the COVID-19 pandemic. JCO Oncology Practice, 16(8), 467-482. [More Information]
• Ahmadzada, T., Cooper, W., Holmes, M., Mahar, A., Westman, H., Gill, A., Nordman, I., Yip, P., Pal, A., Zielinski, R., Pavlakis, N., Nagrial, A., Daneshvar, D., Karikios, D., Grau, G., Hosseini Beheshti, E., Clarke, S., Kao, S., et al (2020). Retrospective evaluation of the use of pembrolizumab in malignant mesothelioma in a real-world Australian population. JTO Clinical and Research Reports, 1(4), 1-15. [More Information]

2019

• Kirby, E., Broom, A., Karikios, D., Harrup, R., Lwin, Z. (2019). Exploring the impact and experience of fractional work in medicine: A qualitative study of medical oncologists in Australia. BMJ Open, 9(12), 1-10. [More Information]

2018

• Wong, W., Kirby, E., Broom, A., Sibbritt, D., Francis, K., Karapetis, C., Karikios, D., Harrup, R., Lwin, Z. (2018). A mixed methods analysis of experiences and expectations among early-career medical oncologists in Australia. Asia-Pacific Journal of Clinical Oncology, 14(5), e521-e527. [More Information]
• Au, L., Turner, N., Wong, H., Field, K., Lee, B., Boadle, D., Cooray, P., Karikios, D., Yip, D., et al (2018). How accurate are medical oncologists' impressions of management of metastatic colorectal cancer in Australia? Asia-Pacific Journal of Clinical Oncology, 14(2), e167-e174. [More Information]
• McEvoy, C., Koe, L., Choong, D., Leong, H., Xu, H., Karikios, D., Plew, J., Prall, O., Fellowes, A., Fox, S. (2018). SDH-deficient renal cell carcinoma associated with biallelic mutation in succinate dehydrogenase A: comprehensive genetic profiling and its relation to therapy response. n p j Precision Oncology, 2(1), 9. [More Information]
• Lwin, Z., Broom, A., Sibbritt, D., Francis, K., Karapetis, C., Karikios, D., Harrup, R. (2018). The Australian Medical Oncologist Workforce Survey: The profile and challenges of medical oncology. Seminars in Oncology, 45, 284-290. [More Information]

2017

• Karikios, D., Mileshkin, L., Martin, A., Ferraro, D., Stockler, M. (2017). Discussing and prescribing expensive unfunded anticancer drugs in Australia. ESMO Open, 2(2), 1-7. [More Information]
• Karikios, D., Chim, L., Martin, A., Nagrial, A., Howard, K., Salkeld, G., Stockler, M. (2017). Is it all about price? Why requests for government subsidy of anticancer drugs were rejected in Australia. Internal Medicine Journal, 47(4), 400-407. [More Information]

2016

• Broom, A., Wong, W., Kirby, E., Sibbritt, D., Karikios, D., Harrup, R., Lwin, Z. (2016). A qualitative study of medical oncologists' experiences of their profession and workforce sustainability. PloS One, 11(11), e0166302. [More Information]
• Lawrence, N., Salkeld, G., Stockler, M., Karikios, D. (2016). Valuing the benefits of new anticancer drugs. Medical Journal of Australia, 204(11), 403-405. [More Information]

2014

• Karikios, D., Schofield, D., Salkeld, G., Robledo, K., Trotman, J., Stockler, M. (2014). Rising cost of anticancer drugs in Australia. Internal Medicine Journal, 44(5), 458-463. [More Information]